Release Date: 02/08/10 15:11 Summary: Becoming a substantial holder from MRX Price Sensitive: No Download Document 5.74MB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling